In this study, we found that SHP2 was not differentially expressed in HCC tumor tissues and adjacent normal tissues and was correlated with the prognosis and development of patients with HCC, indicating that changes in the activity of SHP2 protein rather than changes in its protein expression should be examined to monitor its oncogenic function. The gene discussed is PTPN11; the disease is neoplasm.